Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Seres Therapeutics, Inc. (MCRB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/09/2019 |
GN
| Consolidated Research: 2019 Summary Expectations for Wyndham Hotels & Resorts, Apellis Pharmaceuticals, Transcat, Emerald Expositions Events, Capitala Finance, and Seres Therapeutics — Fundamental Analysis, Key Performance Indications |
| 08/24/2018 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within Seres Therapeutics, Barnes & Noble, Carbo Ceramics, BioLife Solutions, CareDx, and Syntel — New Research Emphasizes Economic Growth |
| 06/19/2018 |
GN
| Report: Exploring Fundamental Drivers Behind Diamondback Energy, Global Net Lease, Ambac Financial Group, IDACORP, Francesca's, and Seres Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments |
| 04/25/2018 |
GN
| New Research Coverage Highlights BWX Technologies, Sparton, Mercury General, Seres Therapeutics, Caleres, and GCP Applied Technologies — Consolidated Revenues, Company Growth, and Expectations for 2018 |
| 02/26/2018 |
GN
| Report: Developing Opportunities within AeroVironment, Seres Therapeutics, HFF, Fluor, KB Home, and H. B. Fuller — Future Expectations, Projections Moving into 2018 |
| 12/19/2017 |
GN
| Report: Exploring Fundamental Drivers Behind Allstate, Ashford Hospitality Prime, S&P Global, Enzo Biochem, Seres Therapeutics, and HFF — New Horizons, Emerging Trends, and Upcoming Developments |
|
|